Michel Azizi (born april 4, 1958) is Professor of Vascular Medicine at Université Paris Cité and Head of the Hypertension Excellence Center and of the Clinical Investigation Center, Georges Pompidou University Hospital, Paris, France. He received his MD from René Descartes University and his PhD from Pierre et Marie Curie University, Paris, France. He is past Vice-President of the European Society of Hypertension (ESH) and current President of the ESH-WG on adherence, pharmacotherpay and lifestyle. His main research interests include the medication- and device-based treatment of resistant hypertension, adherence to treatment and the physiology, genetics and pharmacology of the RAAS. He has published more than 300 papers on his research topics in peer reviewed journals. He has received the Jean Hamburger prize for Medical Research (2007), the Peter van Zwieten award (ESH, 2011), the Paul Milliez award (2017) and the French Ntaional Academy of Medecine award (2022).